Article by hi joiney

IMS latest report predicts that by 2011 China Drugs Sales of more than France and Germany, after the United States and Japan after the world’s third largest pharmaceutical market; in 2013 nearly half of the sales growth from emerging markets 3 16 , IMSHealth has released a report entitled “Rebuilding the World Medicine Market new order: a world divided by re-”(Pharmergingshake-up: NewImperativesinARedefinedWorld) study. Report, the global long-established multinational pharmaceutical companies need to take early action to adapt to a changing world new order drugs, because some emerging-market drug sales will exceed the existing mature markets. 2011 the third largest in China Report predicted that by 2011, China’s pharmaceutical sales to surpass France and Germany to become the third-largest pharmaceutical market, while Brazil British than purchase more drugs. Reported in the patent medicine market, representing leading multinational pharmaceutical companies must take positive action to expand these emerging markets, otherwise they will lose a great opportunity for development, to hand over these markets to local Pharmaceutical companies . The past 8 years, including the United States and Western European countries, including global pharmaceutical sales in mature market annual growth has slowed to single digits. Sales slowdown is the result of the global economic crisis, also due to the major branded drugs lose patents are being protected Generic The use of increasing investment in biotechnology industry is declining, and the Government to implement the pharmaceutical market more stringent control measures. Report showed sales in 2009, the U.S. pharmaceutical market is about 300 billion U.S. dollars, annual growth rate of 5%. According to a recent Credit Suisse report, even if the U.S. Congress passed the Obama health care reform bill, would also stimulate the pharmaceutical sales rose only 10.7 billion U.S. medical reform bill on the U.S. pharmaceutical market minimal impact on growth. Contrast, IMS said that 17 drug sales in emerging markets is expected to grow substantially. Report in accordance with the market value in descending order of growth, these countries (IMS as the emerging pharmaceutical market) is divided into three levels. China alone accounted for the top level; the second level, including Brazil, Russia and India; while the third level, including Venezuela, Poland, Argentina, Turkey and Mexico. Last year, total sales of medicines in these countries to 123 billion U.S. dollars, accounting for the global pharmaceutical sales of more than 7700 billion dollars in 16%. Emerging markets sales growth for the global pharmaceutical industry contributed 37% share. The year 2013, these same countries will re-create 90 billion U.S. dollars of pharmaceutical sales, the growth rate of the global pharmaceutical industry will contribute 48% of the share. IMS company executives said in an interview, general, 2013, the total global pharmaceutical sales, emerging markets will account for about 21% share. Subversive edge of the world economy pattern IMS estimates that by 2013, the increase in emerging markets in drug sales in China will reach 40 billion U.S. dollars. Report, particular concern is the rapid growth of China’s pharmaceutical market, with China’s health care reform in depth, as well as substantial improvements in their health care infrastructure, and strive to achieve universal Health Insurance , 2013, China’s pharmaceutical market size will double. IMS said the growth rate of China’s pharmaceutical market than it had initially forecast even faster. In 2006, IMS forecast in 2011 China will become the world’s sixth-largest pharmaceutical market. The former two markets are the United States and Japan. IMS in 2006, China, Brazil, Mexico, India, Russia, South Korea and Turkey, seven countries in the world’s emerging drug market. South Korea is now a developed market, the other 11 emerging countries are Venezuela, Poland, Argentina, Vietnam, South Africa, Thailand, Indonesia, Romania, Egypt, Pakistan and Ukraine. Report said, now, these traditional marginal economies are equipped to subvert the natural order of the world’s drugs. , Of course, in the global drug sales in developed markets like the U.S. and Japan still holds most of the market. Even so, the report urges multinational pharmaceutical companies to act quickly to rapid growth in the rapid expansion of emerging markets. In these markets, the multinational pharmaceutical companies face has deep roots from the local challenges of pharmaceutical companies, these local companies set up for domestic consumers to accept the brand. Including Novartis, Sanofi – Aventis and GlaxoSmithKline Including a number of European pharmaceutical companies are aggressively work towards, their local pharmaceutical companies or the acquisition or strengthening of local Cooperation Relationship, or invested heavily in developing countries to conduct drug research and development. But on the whole, multinational pharmaceutical companies in emerging markets open up work as expected. The world’s top 15 largest pharmaceutical companies (including Pfizer, Merck and Eli Lilly) for the revenue from emerging markets, less than 10% of total sales. MurrayAitken IMS senior vice president, said in an interview, to be profitable in these emerging countries, multinational pharmaceutical companies need to develop a targeted strategy to address the specific situation of each market and challenges. Some of the emerging pharmaceutical market, particularly the global economic crisis suffered a heavy blow. For example, in Romania, the situation is quite serious, the Turkish pharmaceutical market is in a poor state. Figure 1 Figure 2 Figure 3 Figure 4 Old pharmaceutical companies must take action as soon as possible to the expansion of these emerging markets, otherwise they will lose a great opportunity for development, to hand over profits to local pharmaceutical companies.

www.youtube.com www.encognitive.com Prescription pill addiction is not what first comes to mind when many people think of drug addiction; they tend to think more of addictions to alcohol or illegal drugs. Most people do not think about the possibility of an addiction to a prescription drug; however, prescription pill addiction is becoming more and more common in the United States. Believe it or not, illegal drug usage among teenagers is actually on the decline, but on the negative side, prescription pill addiction is on the rise among out teenagers today. Since this is becoming a growing problem it is important that people become more aware of this type of addiction so they can spot it in friends or family members. In some cases people end up being addicted to prescription drugs unknowingly as their body becomes more and more dependent on the drug. On the other hand, some teenagers and even adults actually seek out prescription drugs because of the great feelings they get when they take them. In fact, there is actually quite a market for prescription pills on the street, with pills like Vicodin selling for up to for one pill, or oxycodone for – www.encognitive.com
Video Rating: 4 / 5

Find More Pharmaceutical Articles